Company Profiles

driven by the PitchBook Platform

Astute Medical

Description

Developer of diagnostic tools for acute medical conditions and diseases. The company is focused on improving diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel diagnostic tests. The company's products have applications related to diagnosis of abdominal pain, cerebrovascular injury, acute coronary syndromes, kidney injury and sepsis.

2007

Founded

PRIVATE

Status

51-200

Employees

Series F

Latest Deal Type

$43M

Latest Deal Amount

$160M

Total Amount Raised

Description

Developer of diagnostic tools for acute medical conditions and diseases. The company is focused on improving diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel diagnostic tests. The company's products have applications related to diagnosis of abdominal pain, cerebrovascular injury, acute coronary syndromes, kidney injury and sepsis.

Website:

www.astutemedical.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Other Devices and Supplies

Primary Office

3550 General Atomics Court Building 02/620 San Diego, CA 92121United States +1 (858) 500-7000
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Astute Medical's full profile, request a free trial.

Astute Medical Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Astute Medical Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Astute Medical Investors (9)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Bio-TechneCorporationMinority000 0000000 0000
CRGGrowth/Expansion000 0000000 0000
Delphi VenturesVenture CapitalMinority000 0000000 0000
De Novo VenturesVenture CapitalMinority000 0000000 0000
Domain AssociatesVenture CapitalMinority000 0000000 0000
Bio-Techne Corporation
CRG Growth/Expansion
Delphi Ventures Venture Capital
De Novo Ventures Venture Capital
Domain Associates Venture Capital

Astute Medical Executive Team (9)

NameTitleBoard
Seat
Contact
Info
Christopher HibberdCo-Founder, Chief Executive Officer & Board Member
W. Todd MyersChief Financial Officer
Philippe BornibusEuropean General Manager
Paul McPherson Ph.DCo-Founder, Chief Scientific Officer & Board Member
Joe Anderberg Ph.DVice President, Development Engineering & Director, Quantitative R&D
Christopher Hibberd Co-Founder, Chief Executive Officer & Board Member
W. Todd Myers Chief Financial Officer
Philippe Bornibus European General Manager
Paul McPherson Ph.D Co-Founder, Chief Scientific Officer & Board Member
Joe Anderberg Ph.D Vice President, Development Engineering & Director, Quantitative R&D

Astute Medical Board Members (8)

NameRepresentingRoleSinceContact
Info
Christopher HibberdAstute MedicalCo-Founder, Chief Executive Officer & Board Member000 0000
David DouglassDelphi VenturesGeneral Partner & Partner Emeritus000 0000
Frederick DotzlerDe Novo VenturesCo-Founder & Managing Director000 0000
James Blair Ph.DDomain AssociatesPartner000 0000
James Scopa JDMPM CapitalManaging Director000 0000
Christopher Hibberd Co-Founder, Chief Executive Officer & Board Member Astute Medical
David Douglass General Partner & Partner Emeritus Delphi Ventures
Frederick Dotzler Co-Founder & Managing Director De Novo Ventures
James Blair Ph.D Partner Domain Associates
James Scopa JD Managing Director MPM Capital
Request full access to PitchBook